BATTIST CHRISTINE
Known title: DirectorCIK: 0001563284
BATTIST CHRISTINE's purchase track record
How the stock did after each of BATTIST CHRISTINE's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
11
of 12 since September 28, 2021
Stock higher 6 months later
36%
3 months: 58%
Median 6-month return
-1.0%
3 months: +2.7%
Beat the S&P 500
18%
median -7.0% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/17/2026 | CSWC | $20K | +4.2% | pending | — |
| 2/9/2026 | CSWC | $14K | +4.2% | +14.3% | +11.3% |
| 8/20/2025 | CSWC | $15K | -5.7% | +9.0% | +7.6% |
| 5/27/2025 | CSWC | $10K | +14.0% | +11.4% | +14.3% |
| 11/8/2024 | CSWC | $6K | +3.1% | -7.4% | -5.6% |
| 8/9/2024 | CSWC | $10K | -1.8% | +1.3% | +12.8% |
| 6/21/2024 | CSWC | $5K | +4.2% | -11.0% | +8.5% |
| 5/29/2024 | CSWC | $5K | -0.4% | -2.9% | +13.9% |
| 11/3/2022 | CSWC | $10K | +7.8% | -1.0% | +9.2% |
| 2/17/2022 | CSWC | $10K | -9.2% | -11.9% | -2.2% |
| 12/20/2021 | CSWC | $10K | -0.2% | -18.9% | -17.6% |
| 9/28/2021 | CSWC | $18K | +2.2% | -0.6% | +6.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CSWC | ▲ Buy | Grant | 1,989 | $0 | 8/10/2026 | View on chart |
| CSWC | ▲ Buy | Open Market | 860 | $20K | 6/17/2026 | View on chart |
| CSWC | ▲ Buy | Open Market | 600 | $14K | 2/9/2026 | View on chart |
| CSWC | ▲ Buy | Open Market | 667 | $15K | 8/20/2025 | View on chart |
| CSWC | ▲ Buy | Grant | 2,193 | $0 | 8/12/2025 | View on chart |
| CSWC | ▲ Buy | Open Market | 476 | $10K | 5/27/2025 | View on chart |
| CSWC | ▲ Buy | Open Market | 256 | $6K | 11/8/2024 | View on chart |
| CSWC | ▲ Buy | Grant | 2,090 | $0 | 8/9/2024 | View on chart |
| CSWC | ▲ Buy | Open Market | 406 | $10K | 8/9/2024 | View on chart |
| CSWC | ▲ Buy | Open Market | 197 | $5K | 6/21/2024 | View on chart |
| CSWC | ▲ Buy | Open Market | 192 | $5K | 5/29/2024 | View on chart |
| CSWC | ▲ Buy | Grant | 2,240 | $0 | 8/10/2023 | View on chart |
| CSWC | ▲ Buy | Open Market | 510 | $10K | 11/3/2022 | View on chart |
| CSWC | ▲ Buy | Grant | 2,421 | $0 | 8/10/2022 | View on chart |
| CSWC | ▲ Buy | Open Market | 389 | $10K | 2/17/2022 | View on chart |
| CSWC | ▲ Buy | Open Market | 400 | $10K | 12/20/2021 | View on chart |
| CSWC | ▲ Buy | Open Market | 700 | $18K | 9/28/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Capital Southwest (CSWC) dividend focus as UBS lifts target
Capital Southwest reported a dividend yield above 10%, keeping it in recent dividend‑stock round‑ups. UBS kept its rating neutral but raised its price target to $24, reflecting optimism despite a neutral stance. The stock trades near its long‑term support level around $22.9, with a trailing P/E of 13.6.
Capital Southwest (CSWC) dividend focus as UBS lifts target. Capital Southwest reported a dividend yield above 10%, keeping it in recent dividend‑stock round‑ups. UBS kept its rating neutral but raised its price target to $24, reflecting optimism despite a neutral stance. The stock trades near its long‑term support level around $22.9, with a trailing P/E of 13.6.